Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia

Hypersplenism and thrombocytopenia are common complications of liver cirrhosis or thalassemia, but current treatment strategies are limited. This study aimed to evaluate the efficacy and safety of thalidomide in the treatment of hypersplenism and thrombocytopenia in patients with liver cirrhosis or...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yaocheng, Cai, Ning, Lai, Yongrong, Xu, Weiwei, Li, Jinyan, Huang, Lan, Huang, Ying, Hu, Meiling, Yang, Huangju, Chen, Jiangming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394185/
https://www.ncbi.nlm.nih.gov/pubmed/32792958
http://dx.doi.org/10.3389/fphar.2020.01137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394185/
https://www.ncbi.nlm.nih.gov/pubmed/32792958
http://dx.doi.org/10.3389/fphar.2020.01137

Ejemplares similares